Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-12

Clinical Trial Update: Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment

View source ↗

Summary

This clinical trial update reports results on the prevalence and incidence of articular symptoms related to psoriatic arthritis in patients with psoriasis treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Humira (adalimumab)

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Psoriasis, Psoriatic Arthritis | Status: COMPLETED | Results posted: 2015-05-12